Heike I Grabsch1,2, Piet A van den Brandt3,4, Josien C A Jenniskens3, Kelly Offermans3, Colinda C J M Simons3, Iryna Samarska1, Gregorio E Fazzi1, Kim M Smits1, Leo J Schouten3, Matty P Weijenberg3. 1. Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands. 2. Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom. 3. Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands. 4. Department of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center+, Maastricht, the Netherlands.
Authors: Josien C A Jenniskens; Kelly Offermans; Colinda C J M Simons; Iryna Samarska; Gregorio E Fazzi; Jaleesa R M van der Meer; Kim M Smits; Leo J Schouten; Matty P Weijenberg; Heike I Grabsch; Piet A van den Brandt Journal: J Cancer Res Clin Oncol Date: 2022-05-11 Impact factor: 4.322
Authors: Josien C A Jenniskens; Kelly Offermans; Colinda C J M Simons; Iryna Samarska; Gregorio E Fazzi; Kim M Smits; Leo J Schouten; Matty P Weijenberg; Heike I Grabsch; Piet A van den Brandt Journal: Int J Cancer Date: 2022-02-05 Impact factor: 7.316